{"adverse_reactions":["Sincerus Florida, LLC. Adverse reactions ss"],"components":["Active, inactive dd"],"effective_time":"20190514","id":"88df0f6a-620d-6a38-e053-2a95a90a3a8d","instructions_for_use":["Directions for use df"],"openfda":{},"package_label_principal_display_panel":["NDC 72934- 2113-2 HYDROCORTISONE 2.5% / LEVOCETIRIZINE DIHYDROCHLORIDE 2%. Gel 30gm. sad"],"set_id":"88df0f6a-620c-6a38-e053-2a95a90a3a8d","spl_product_data_elements":["HYDROCORTISONE 2.5% / LEVOCETIRIZINE DIHYDROCHLORIDE 2% HYDROCORTISONE 2.5% / LEVOCETIRIZINE DIHYDROCHLORIDE 2% HYDROCORTISONE HYDROCORTISONE LEVOCETIRIZINE DIHYDROCHLORIDE LEVOCETIRIZINE"],"version":"1"}